Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

58.50 -0.08 (-0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,720,231
Open 58.88
Bid (Size) 57.90 (1)
Ask (Size) 59.65 (1)
Prev. Close 58.58
Today's Range 57.55 - 58.94
52wk Range 52.93 - 93.04
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 of Wall Street’s Favorite Stocks to Consider Right Now
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
2 Reasons to Watch BMRN and 1 to Stay Cautious
Over the past six months, BioMarin Pharmaceutical’s stock price fell to $57. Shareholders have lost 17.1% of their capital, which is disappointing considering the S&P 500 has climbed by 4.7%. This may... 
Via StockStory
Topics Stocks

Performance

YTD
-12.0%
-12.0%
1 Month
-0.9%
-0.9%
3 Month
+0.7%
+0.7%
6 Month
-15.2%
-15.2%
1 Year
-35.0%
-35.0%

More News

Read More
Predicting the Next Rule Breaker Buyout
Via The Motley Fool
Topics Artificial Intelligence
Earnings Scheduled For August 4, 2025
Via Benzinga
Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter
Via Benzinga
Topics Stocks
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
Via StockStory
Topics Earnings Economy
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN): A Prime Value Investment with Strong Fundamentals and Growth Potential
Via Chartmill
BMRN Q2 Deep Dive: Pipeline Advances and Strategic Expansion Drive Upbeat Results
Via StockStory
Is BioMarin Pharmaceutical Gaining or Losing Market Support?
Via Benzinga
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
Via Benzinga
BioMarin (BMRN) Q2 Revenue Jumps 16%
Via The Motley Fool
Topics Economy
BioMarin (BMRN) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Strong Q2 Numbers, Stock Soars
Via StockStory
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Exceeds Q2 2025 Earnings Expectations, Shares Climb After Hours
Via Chartmill
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence Economy World Trade
What's Next: Biomarin Pharmaceutical's Earnings Preview
Via Benzinga
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
Via Benzinga
1 Mid-Cap Stock Worth Investigating and 2 We Turn Down
Via StockStory
What Does the Market Think About BioMarin Pharmaceutical?
Via Benzinga
Demystifying BioMarin Pharmaceutical: Insights From 4 Analyst Reviews
Via Benzinga
1 Cash-Producing Stock to Consider Right Now and 2 We Ignore
Via StockStory
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock Worth Watching
Via Chartmill
Nasdaq Bull Market: 3 Historically Cheap Stocks That Can Easily Double Your Money
Via The Motley Fool
Topics Economy Stocks
Unpacking Q1 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock With Strong Fundamentals
Via Chartmill

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 58.50
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 08/25/25 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.73B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.